Federal Circuit Court

Alzheon Announces that United States Federal Circuit Affirmed Decision of U.S. Patent Office Invalidating Risen (Suzhou) Pharmaceutical Technology Co., Ltd.’s Patent on Isotopically Enriched Forms of ALZ-801/Valiltramiprosate

Retrieved on: 
Monday, April 8, 2024
Biotechnology, Professional Services, Health, Patent Law, Pharmaceutical, Neurology, Research, Genetics, Legal, Science, Clinical Trials, Comment, Patent, Patient, NDA, PTAB, Federal Circuit Court, Doctor of Philosophy, IPR, Prodrug, Rule 34, Pharmaceutical industry

The decision was affirmed without discussion by the Federal Circuit Court (Case No.

Key Points: 
  • The decision was affirmed without discussion by the Federal Circuit Court (Case No.
  • In 2020, Alzheon petitioned the Patent Trial and Appeal Board (PTAB) of the U.S. Patent Office (USPTO) to institute an Inter-Parties Review (IPR) of Risen’s U.S. Patent No.
  • Risen appealed the PTAB’s decision to the United States Court of Appeals for the Federal Circuit.
  • “Alzheon is pleased that the U.S. Federal Circuit affirmed the Patent Trial and Appeal Board’s decision to invalidate all claims of Risen’s patent.

SmartSky Reaffirms the Merits of its Patent Infringement Case Against Gogo Business Aviation

Retrieved on: 
Wednesday, January 31, 2024
Gogo Business Aviation, Patent, Aviation, District court, Federal Circuit Court, Go go

RESEARCH TRIANGLE, N.C., Jan. 31, 2024 /PRNewswire/ -- In response to the Federal Circuit Court of Appeals decision today, which did not reverse a District Court denial of a preliminary injunction, SmartSky reaffirms the merits of its patent infringement case (C.A.

Key Points: 
  • RESEARCH TRIANGLE, N.C., Jan. 31, 2024 /PRNewswire/ -- In response to the Federal Circuit Court of Appeals decision today, which did not reverse a District Court denial of a preliminary injunction, SmartSky reaffirms the merits of its patent infringement case (C.A.
  • 22-266-GBW) against Gogo Business Aviation originally filed in February of 2022.
  • The appellate decision was based solely on the issue of irreparable harm and did not address any of SmartSky's patent infringement claims at this preliminary stage of the case.
  • While preliminary injunctions are rarely granted, SmartSky was compelled to seek such extraordinary relief given the allegations ofGogo's egregious infringement.

Intellectual Property Trial Lawyer Alfonso Chan Joins King & Spalding in Austin

Retrieved on: 
Wednesday, December 13, 2023
King & Spalding, University, Methodist University, Rensselaer Polytechnic Institute, Materials science, McKool Smith, Southern Methodist University, Semiconductor, Engineering, Federal Circuit Court

AUSTIN, Texas, Dec. 13, 2023 /PRNewswire/ -- King & Spalding announced today that leading intellectual property lawyer Alfonso Chan has joined the firm as a partner in its Trial and Global Disputes Practice Group.

Key Points: 
  • AUSTIN, Texas, Dec. 13, 2023 /PRNewswire/ -- King & Spalding announced today that leading intellectual property lawyer Alfonso Chan has joined the firm as a partner in its Trial and Global Disputes Practice Group.
  • Chan is a trial lawyer who focuses on litigating and licensing complex intellectual property cases on behalf of universities, research institutes and technology companies, with a primary focus on matters involving semiconductors and other electronic technologies, biomaterials and medical devices.
  • "Alfonso is an enterprising lawyer who has built an impressive practice, and we are excited to bring his energy and drive to our IP and trial teams."
  • Chan joins King & Spalding from McKool Smith.

Hon. Pauline Newman Passes Medical Evaluation with Flying Colors, Forensic Psychologist Says

Retrieved on: 
Thursday, September 7, 2023
United States Court of Appeals for the Federal Circuit, Federal Circuit Court, University, Committee, Judicial Council, Special, Federal, Tuskegee Veterans Administration Medical Center, Hon, Hearing, Behavioural sciences, Psychiatry, Judiciary, NCLA, Miami, George Washington University, Audit, Medical device, Medicine

Pauline Newman, whose fellow judges are unlawfully attempting to oust her from a constitutionally appointed lifetime position as a Federal Circuit Court of Appeals judge.

Key Points: 
  • Pauline Newman, whose fellow judges are unlawfully attempting to oust her from a constitutionally appointed lifetime position as a Federal Circuit Court of Appeals judge.
  • A new video released by NCLA exposes the unjust treatment of Judge Newman and showcases her vibrant mind, vigor, and dignity for all to see.
  • Dr. Regina M. Carney, a full-time forensic psychologist at Miami Veteran’s Administration Medical Center, and an Assistant Professor in the Department of Psychiatry and Behavioral Sciences at the University of Miami’s Leonard M. Miller School of Medicine, performed a three-hour medical evaluation of Judge Newman on August 25.
  • NCLA released the following statements:
    “Two independent medical providers have now evaluated Judge Newman and found her to competent to serve as a federal judge.

Sanofi Applauds Supreme Court Ruling Supporting Scientific Innovation by Striking Down Amgen's Asserted PCSK9 Patent Claims in Amgen v Sanofi

Retrieved on: 
Thursday, May 18, 2023
Government, SNY, Federal Circuit Court, Research, Patient, Patent, Regeneron Pharmaceuticals, Judge, Supreme court, Sanofi, Amgen

Decision unanimously affirms the United States Federal Circuit Court's opinion that Amgen's asserted U.S. PCSK9 patent claims are invalid

Key Points: 
  • Decision unanimously affirms the United States Federal Circuit Court's opinion that Amgen's asserted U.S. PCSK9 patent claims are invalid
    BRIDGEWATER, N.J., May 18, 2023 /PRNewswire/ -- Sanofi (NASDAQ: SNY) is pleased with the United States Supreme Court's ruling in Amgen v. Sanofi et.
  • The decision unanimously affirms the United States Federal Circuit Court's opinion that is favorable to Sanofi and Regeneron.
  • This ruling reinforces our longstanding belief that Amgen's asserted patent claims are invalid and represents an unequivocal win for America's innovation economy, its scientists, and researchers.
  • We thank the Justices and the many groups, individuals and the U.S. government who supported our defense of scientific innovation.

TeleChoice resolution provides remedy to affected individuals and offers better security for all customers

Retrieved on: 
Monday, October 31, 2022
Review, Channel 9, OAIC, Risk, Office of the Australian Information Commissioner, Privacy Act (Canada), 992, Privacy, Privacy Act, Maintenance, Commissioner, Unenforceable, Compliance, TeleChoice, Federal court, Judgement of the German Federal Court of Justice on Google's autocomplete function, Record, APP, Federal Circuit Court, Disclosure, Private investigator, Risk management, Online shopping, Public relations

= TeleChoice resolution provides remedy to affected individuals and offers better security for all customers =

Key Points: 
  • = TeleChoice resolution provides remedy to affected individuals and offers better security for all customers =
    The Acting Australian Information Commissioner, Timothy Pilgrim, has accepted an enforceable undertaking from Business Service Brokers Pty Ltd (trading as TeleChoice), following an incident in which the personal information of former TeleChoice customers was found in a shipping container located on publically accessible land.
  • The information included the records of individuals who were TeleChoice customers prior to 31 March 2013.
  • Australian customers expect that organisations will handle their personal information securely, and are entitled to this under the Privacy Act, Mr Pilgrim said.
  • The OAIC will continue to liaise with TeleChoice to ensure that it meets its obligations in the enforceable undertaking.
  • When TeleChoice became aware of this, it immediately removed all of the customer personal information and destroyed it, except for a small sample.
  • As a result of this, TeleChoice is unable to determine the identity of the customers affected by this incident.
  • TeleChoice advised that only customer records prior to 31 March 2013 may have been stored in the containers, which means only individuals who were TeleChoice customers prior to this may have been affected by this incident.
  • Individuals who think they may have been affected by this incident can contact TeleChoice at [email protected].
  • Individuals can contact the OAICs Enquiries Line for further information about the Privacy Act 1988 (Cth) and their privacy rights, on 1300 363 992 or [email protected].

‘HW’ and Freelancer International Pty Limited

Retrieved on: 
Monday, October 31, 2022
Review, Federal Court of Australia, Commissioner, Privacy Act 1988, Federal Circuit Court of Australia, Administrative Appeals Tribunal, Federal court, Privacy, Federal Circuit Court, Publishing

HW and Freelancer International Pty Limited

Key Points: 
  • HW and Freelancer International Pty Limited
    13 January 2016
    Under the Privacy Act 1988, the Australian Information Commissioner can make a determination on a privacy complaint where the matter has not been able to be resolved through conciliation or finalised on some other basis.
  • In HW and Freelancer International Pty Limited, the Commissioner found that Freelancer had breached the complainants privacy.
  • The full determination is available at HW and Freelancer International Pty Limited [2015] AICmr 86 (18 December 2015).
  • Parties to a determination are able to seek review of the decision through the Administrative Appeals Tribunal or through the Federal Circuit Court or Federal Court of Australia.

Xebra Completes Last Legal Requirement to Receive Mexican Cannabis Authorizations

Retrieved on: 
Tuesday, August 30, 2022
CBD, THC, CEO, Prospectus, CSE, USMCA, Agriculture, EBITDA, Seed, Oil, Calendar, Emulsion, Element, Federal Circuit Court, Sale, Risk, Federal Circuit Court of Australia, FSE, Forward-looking statement, SA, Multimedia, COFEPRIS, Law of the United Kingdom, Supreme court, Company, Drink, Cannabis, Compliance, Biomass, Transport, Acquisition, Growth, Xebra, Drug, BC

Xebra announced on December 2nd, 2021, that all five Supreme Court justices voted unanimously in favor of granting Xebra's wholly owned Mexican subsidiary, Desart MX, SA de CV ("Xebra Mexico"), an irrevocable cannabis injunction.

Key Points: 
  • Xebra announced on December 2nd, 2021, that all five Supreme Court justices voted unanimously in favor of granting Xebra's wholly owned Mexican subsidiary, Desart MX, SA de CV ("Xebra Mexico"), an irrevocable cannabis injunction.
  • "We are thrilled that there are no more legal hurdles to overcome, said Jay Garnett, CEO of Xebra.
  • "The final step in the process is for the Mexican Health Regulatory Agency (COFEPRIS) to grant Xebra Mexico all cannabis authorizations per our Amparo, and we expect that to happen soon!"
  • Xebra believes Mexico has the potential to be one of the largest near-term country cannabis consumer markets in the world.

Federal Circuit Rules in Favor of Natera, Upholding Invalidation of CareDx Patents

Retrieved on: 
Monday, July 18, 2022
SEC, CLIA, Patient, Risk, ISO, Clinical Laboratory, DNA, Genetic testing, NASDAQ, Multimedia, NTRA, Nucleic acid thermodynamics, Laboratory, Health, Form 10-K, Federal Circuit Court, Natera

"We are pleased that multiple courts have rejected CareDx's baseless claims against Natera's proprietary technology," said Daniel Rabinowitz, chief legal officer, Natera.

Key Points: 
  • "We are pleased that multiple courts have rejected CareDx's baseless claims against Natera's proprietary technology," said Daniel Rabinowitz, chief legal officer, Natera.
  • "Natera is a leading innovator of cfDNA testing, and we remain focused on serving the transplant community, including our many physician partners and patients."
  • Natera is a global leader in cell-free DNA testing, dedicated to oncology, women's health, and organ health.
  • These forward-looking statements represent Natera's expectations as of the date of this press release, and Natera disclaims any obligation to update the forward-looking statements.

McKool Smith Welcomes Patent Pro and University IP Specialist Alfonso Chan

Retrieved on: 
Wednesday, July 6, 2022
Dedman School of Law, Engineering, University, Materials science, PTAB, McKool Smith, Federal Circuit Court, Rensselaer Polytechnic Institute, Patent Trial and Appeal Board, Industry, Intellectual property, Graduate certificate, Bankruptcy, USPTO, IP, Judge Advocate General's Corps, U.S. Navy, Methodist University, Materials Science and Engineering, Southern Methodist University, Lawyer, Bettis Atomic Power Laboratory

DALLAS, July 6, 2022 /PRNewswire/ -- McKool Smith has announced that patent litigator Alfonso Chan has joined the firm as a principal in its Dallas office.

Key Points: 
  • DALLAS, July 6, 2022 /PRNewswire/ -- McKool Smith has announced that patent litigator Alfonso Chan has joined the firm as a principal in its Dallas office.
  • "Alfonso is an experienced patent litigator with a deep specialization in representing universities in complex IP disputes and licensing matters," said McKool Smith Chairman and Managing Partner David Sochia .
  • "McKool Smith's reputation and proven success in high-stakes IP cases are second to none," said Mr. Chan.
  • McKool Smith represents clients in complex commercial litigation, intellectual property, bankruptcy, insurance recovery, and white collar defense matters.